ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /化合物

Ferric cation

HCID 29936
ノートを作成反応を作成見積依頼を出す
印刷プレビュー
基本情報概要名称と識別子物性化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
20074-52-6
標準SMILES
[Fe+3]
InChIKey
VTLYFUHAOXGGBS-UHFFFAOYSA-N
分子式
Fe+3
平均分子量
55.84 g/mol
単同位体質量
55.93329176

概要

Iron(3+) is an iron cation and a monoatomic trication. It has a role as a cofactor, a mouse metabolite, an Escherichia coli metabolite and a human metabolite.

名称と識別子

優先名称
Ferric cation
IUPAC
iron(3+)
英語名
IRONIII
分子式
Fe+3
分子量
55.845

名称と別名

Ferric ionFerric cationFerric ionsUNII-91O4LML61191O4LML611RefChem:7375Iron(3+)20074-52-6Fe3+iron(III)Iron(3+) ionferric iron
名称をさらに表示
FERRICION
Iron, ion (Fe3+)Iron(III) cationIron(III) ionFe(III)Iron(3+)ionsIron trivalent ionFeIIIIron (III) ion

データベース識別子

CAS
20074-52-6、7439-89-6
PubChem CID
29936
DTXSID
DTXSID9041029
ChEBI
CHEBI:29034
UNII
91O4LML611
Nikkaji
J2.513.812K

物性

構造計算による物性

極性表面積
0 Ų
水素結合供与体数
0
水素結合受容体数
0
回転可能結合数
0
重原子数
1
形式電荷
3
複雑度
0

実験および物理化学的性質

SolubilityInsoluble
Melting Point1538 °C
Physical DescriptionSolid

物理化学的性質

EPAの化学物質情報
Ferric ion (20074-52-6)

化学と産業

薬理情報

Protein Binding · 1 件

Fe3+ is converted to Fe2+, which is bound and transported in the body via circulating transferrin. In pathogenic _Neisseria_, ferric iron-binding protein serves as the main periplasmic-protein for ferric iron that has equivalence to human transferrin. Once in the cytosol, ferric iron is stored in ferritin where it is associated with hydroxide and phosphate anions.

Pharmacodynamics · 1 件

When Fe3+ is converted to soluble Fe2+, it primarily exists in the circulation in the complex forms bound to protein (hemoprotein) as heme compounds (hemoglobin or myoglobin), heme enzymes, or nonheme compounds (flavin-iron enzymes, transferring, and ferritin). Once converted, Fe2+ serves to support various biological functions. Iron promotes the synthesis of oxygen transport proteins such as myoglobin and hemoglobin, and the formation of heme enzymes and other iron-containing enzymes involved in electron transfer and redox reactions. It also acts as a cofactor in many non-heme enzymes including hydroxylases and ribonucleotide reductase. Iron-containing proteins are responsible in mediating antioxidant actions, energy metabolism, oxygen sensing actions, and DNA replication and repair. Saturation of transferrin from high concentrations of unstable iron preparations may elevate the levels of weakly transferrin-bound Fe3+, which may induce oxidative stress by catalyzing lipid peroxidation and reactive oxygen species formation.

Mechanism of Action · 1 件

Iron is incorporated into various proteins to serve biological functions as a structural component or cofactor. Once ferric or ferrous cation from intestinal enterocytes or reticuloendothelial macrophages is bound to circulating transferrin, iron-transferrin complex binds to the cell-surface transferrin receptor (TfR) 1, resulting in endocytosis and uptake of the metal cargo. Internalized iron is transported to mitochondria for the synthesis of heme or iron-sulfur clusters, which are integral parts of several metalloproteins. Excess iron is stored and detoxified in cytosolic ferritin. Internalized Fe2+ exported across the basolateral membrane into the bloodstream via Fe+2 transporter ferroportin, which is coupled by reoxidation to Fe3+ via membrane-bound ferroxidase hephaestin or ceruloplasmin activity. Fe+3 is again scavenged by transferrin which maintains the ferric iron in a redox-inert state and delivers it into tissues. Fe3+ participates in the autoxidation reaction, where it can be chelated by DNA. It mainly binds to the backbone phosphate group, whereas at higher metal ion content, the cation binds to both guanine N-7 atom and the backbone phosphate group.

関連反応

68 件
反応記録を作成
HRID 89333 の反応式
HRID 89333反応物としてTraining data from https://doi.org/10.1039/C8SC04228D (2/10)
HRID 91927 の反応式
HRID 91927反応物としてTraining data from https://doi.org/10.1039/C8SC04228D (2/10)
HRID 93806 の反応式
HRID 93806反応物としてTraining data from https://doi.org/10.1039/C8SC04228D (2/10)
HRID 104245 の反応式
HRID 104245反応物としてTraining data from https://doi.org/10.1039/C8SC04228D (2/10)
HRID 105803 の反応式
HRID 105803反応物としてTraining data from https://doi.org/10.1039/C8SC04228D (2/10)
HRID 106926 の反応式
HRID 106926反応物としてTraining data from https://doi.org/10.1039/C8SC04228D (2/10)
HRID 135241 の反応式
HRID 135241反応物としてTraining data from https://doi.org/10.1039/C8SC04228D (9/10)
HRID 148550 の反応式
HRID 148550反応物としてTraining data from https://doi.org/10.1039/C8SC04228D (9/10)
1 / 9 ページ

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性化学と産業関連反応化合物ノート
その他の操作
ノートを作成反応を作成見積依頼を出す
Biological Half-LifeThe pharmacokinetic properties of ferric compounds vary.
Metabolism/MetabolitesFerric cation is converted to ferrous iron by duodenal cytochrome B reductase. Ferritin may also convert ferric to ferrous iron.
FDA Pharmacological Classification · 6 件

91O4LML611

FERRIC CATION

Chemical Structure [CS] - Iron

Established Pharmacologic Class [EPC] - Parenteral Iron Replacement

Established Pharmacologic Class [EPC] - Phosphate Binder

Mechanisms of Action [MoA] - Phosphate Chelating Activity

Absorption, Distribution and Excretion · 4 件

Iron absorption and systemic iron homeostasis are regulated by hepcidin, which is a peptide hormone that also regulates the activity of the iron-efflux protein, ferroportin-1. Iron is mostly absorbed in the duodenum and upper jejunum. Fe3+ displays low solubility at the neutral pH of the intestine and is mainly be converted to ferrous iron (Fe2+) by ferric reductases, as ferric salts are only half as well absorbed as ferrous salts. Once converted in the intestinal lumen, Fe+2 is transported across the apical membrane of enterocytes. The absorption rate of non-haem iron is 2-20%. Stored iron may be liberated via ferroportin-mediated efflux, which is coupled by reoxidation of Fe2+ to Fe3+ by ceruloplasmin in the serum or hephaestin in the enterocyte membrane. Fe3+ subsequently binds to transferrin, which keeps ferric cation in a redox-inert state and delivers it into tissues. It is proposed that there may be separate cellular uptake pathways for ferrous iron and ferric iron. While ferrous iron is primarily carried by divalent metal transporter-1 (DMAT-1), cellular uptake of ferric iron is predominantly mediated by beta-3 integrin and mobilferrin, which is also referred to as calreticulin in some sources as a homologue. However, the most dominant pathway in humans is unclear.

Iron is predominantly conserved in the body with no physiologic mechanism for excretion of excess iron from the body, other than blood loss. The pharmacokinetic properties of ferric compounds vary.

Less than 65% of iron is stored in the liver, spleen, and bone marrow, mainly as ferritin and haemosiderin. The pharmacokinetic properties of ferric compounds vary.

The rate of iron loss is approximately 1 mg/day. The pharmacokinetic properties of ferric compounds vary.

Metabolite Pathways27-Hydroxylase Deficiency